A lawsuit loan is just like any other loan: a financial instrument allowing you to obtain resources for a specific use and repay them over time, with an interest rate.

Stevens-Johnson syndrome is a life-threatening condition characterized by severe skin rash, blisters in the mucous membranes and shedding of the skin. The disease is very serious and can result in lasting complications and death. A more severe form of the same condition is toxic epidermal necrolysis.

Like most medications, Flagyl® may cause a variety of side effects. Some of these side effects can lead to complications that may be fatal.

Like other nonsteroidal anti-inflammatory drugs (NSAIDs), Naprosyn® (generically known as naproxen) is prescribed to treat the pain associated with arthritis, tendinitis, bursitis, gout and menstrual cramps. Naprosyn® may also be distributed under the brand names EC-Naprosyn®, Anaprox®/Anaprox® DS.

Manufactured by Pfizer, Neurontin® (generically referred to as gabapentin) is an anti-convulsant medication that was first approved for the treatment of epilepsy by the U.S. Food and Drug Administration (FDA) in 1994.

Administered via injection, Remicade® (generically referred to as infliximab) is a prescription medication used in the treatment of autoimmune diseases, including Crohn's disease, psoriasis and rheumatoid arthritis.

First discovered in 1979, Topamax® (topiramate) is an epilepsy medication available via prescription and produced by Ortho-McNeil Nuerologics and Noramac, Inc. (both of which are subsidiaries of Johnson & Johnson).

Incivek (telaprevir) is a hepatitis C drug that is taken in combination with peginterferon alfa and ribavirin (Incivek combination treatment).

Allopurinol® (Zyloprim) is a drug intended for the treatment of gout. Some patients reported to have developed Stevens-Johnson syndrome or toxic epidermal necrolysis due to a severe allergic reaction to the medication.

On April 30, 2010, unexpired lots of Children's and Infants' liquid Motrin® were recalled by the U.S. Food and Drug Administration (FDA) and the products' manufacturer.

First approved by the U.S. Food and Drug Administration (FDA) in December 1994, Lamictal® (generically referred to as lamotrigine) is a prescription drug indicated for the treatment of epilepsy, specifically partial seizures, primary and secondary tonic-clonic seizures and the symptoms of Lennox-Gastaut syndrome.

First approved by the U.S. Food and Drug Administration (FDA) in November 2001, Bextra® (generically referred to as valdecoxib) is a prescription medication that was pulled from U.S. markets in 2005 due to mounting concerns that the drug had the potential to cause serious, life-threatening side effects.

Children's Tylenol® is a popular, well-known medication used to treat fever and aches and pains. Parents have relied on Children's Tylenol® for a long time.

Children's Advil®, whose main active ingredient is ibuprofen, is part of a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs).

Classified as a nonsteroidal anti-inflammatory drug (NSAID), Daypro® (generically known as oxaprozin and also sold under the brand name Duraprox®) is a prescription tablet used to treat the chronic pain associated with osteoarthritis, rheumatoid arthritis and juvenile rheumatoid arthritis.

Classified as a nonsteroidal anti-inflammatory drug (NSAID), diclofenac is a prescription medication that is indicated in the treatment of osteoarthritis, rheumatoid arthritis, dental pain, gout, kidney pain, menstrual pain and dysmenorrhea.

Distributed by Merck & Co., Dolobid® (generically referred to as Diflunisal) is a nonsteroidal anti-inflammatory drug (NSAID) that is prescribed for the treatment of rheumatoid arthritis, osteoarthritis and/or any type of mild to moderate chronic pain (especially that resulting from dental surgery).

Dilantin® is an anti-seizure medication to treat epilepsy. It is manufactured by Pfizer and was developed in 1938. Its generic name is phenytoin.

A warning about the link between acetaminophen and a serious and possibly lethal skin condition known as Stevens-Johnson syndrome (SJS) was recently issued by the FDA.

The FDA published a warning about the link between Tylenol® and other acetaminophen products and a rare skin condition called Stevens-Johnson syndrome (SJS) in August, 2013.